Identification of Genetic Variants Using Next-Generation Sequencing in Pediatric Myelodysplastic Syndrome: From Disease Biology to Clinical Applications
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26146907 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Viviane Lamim Lovatel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cytogenetic Laboratory, Cell and Gene Therapy Program, Instituto Nacional de Câncer (INCA), Rio de Janeiro 20230-130, RJ, Brazil. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Myelodysplastic Syndromes, Genetic Variation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Carlos Chagas Filho de Amaro à Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro—FAPERJ, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Abstract (Originalsprache)
This study aimed to identify genetic variants using a customized next-generation sequencing (NGS) panel for pediatric myelodysplastic syndrome (pMDS) and to explore their associations with cytogenetic and clinical characteristics. Cytogenetic analyses were conducted using G-banding and fluorescence in situ hybridization. NGS was performed with the Ion Torrent Personal Genome Machine for the following genes: GATA2, RUNX1, CEBPA, ANKRD26, ETV6, SAMD9, SAMD9L, PTPN11, NRAS, SETBP1, DDX41, TP53, FLT3, SRP72, and JAK3. Analyses were performed with Ion Reporter 5.20.8.0 software. Genetic variants were classified using the dbSNP, 1000 Genomes, COSMIC, and Varsome databases. We analyzed 25 cases of pMDS; 15 presented abnormal karyotypes, and 19 showed genetic variants. Among the 29 variants identified across 12/15 genes, 27% were pathogenic and 14% were likely pathogenic, with NRAS and GATA2 most frequently associated with disease progression. A new somatic variant of uncertain significance in SETBP1 was detected in seven patients showing heterogeneous clinical outcomes. Genetic variants were found in 7/10 patients with normal karyotypes, indicating that submicroscopic alterations can shed light on disease biology. Our results highlight the critical role of a targeted NGS panel in identifying molecular alterations associated with pMDS pathogenesis, thereby enhancing diagnostic precision, prognosis, and aiding in treatment selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cytogenetic Laboratory, Cell and Gene Therapy Program, Instituto Nacional de Câncer (INCA), Rio de Janeiro 20230-130, RJ, Brazil.
- Stem Cell Laboratory, Instituto Nacional de Câncer, Rio de Janeiro 20230-130, RJ, Brazil.
- Bone Marrow Transplantation Center, Instituto Nacional de Câncer (INCA), Rio de Janeiro 20230-130, RJ, Brazil.
- Faculdade de Medicina, Instituto de Pediatria e Puericultura Martagão Gesteira, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-912, RJ, Brazil.
ORCID-Profile: Viviane Lamim Lovatel, Gerson Moura Ferreira, Beatriz Ferreira da Silva, Rayane de Souza Torres, Eliana Abdelhay, Teresa de Souza Fernandez
Förderung
- Fundação Carlos Chagas Filho de Amaro à Pesquisa do Estado do Rio de Janeiro (FAPERJ)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro—FAPERJ
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Zitieren
APA
Lovatel, V. L., Ferreira, G. M., da Silva, B. F., de Souza Torres, R., de Cássia Barbosa da Silva Tavares, R., Bueno, A. P. S., Abdelhay, E., & de Souza Fernandez, T. (2025). Identification of Genetic Variants Using Next-Generation Sequencing in Pediatric Myelodysplastic Syndrome: From Disease Biology to Clinical Applications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146907
Vancouver
Lovatel VL, Ferreira GM, da Silva BF, de Souza Torres R, de Cássia Barbosa da Silva Tavares R, Bueno APS, et al. Identification of Genetic Variants Using Next-Generation Sequencing in Pediatric Myelodysplastic Syndrome: From Disease Biology to Clinical Applications. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146907
BibTeX
@article{Lovatel2025,
author = {Lovatel, Viviane Lamim and Ferreira, Gerson Moura and da Silva, Beatriz Ferreira and de Souza Torres, Rayane and de Cássia Barbosa da Silva Tavares, Rita and Bueno, Ana Paula Silva and Abdelhay, Eliana and de Souza Fernandez, Teresa},
title = {Identification of Genetic Variants Using Next-Generation Sequencing in Pediatric Myelodysplastic Syndrome: From Disease Biology to Clinical Applications},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26146907}
}
EUVIMED